Jörg Dietrich
Massachusetts General Hospital(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Cancer-related cognitive impairment studies, CNS Lymphoma Diagnosis and Treatment, CAR-T cell therapy research
Most-Cited Works
- → Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial(2017)644 cited
- → Corticosteroids in brain cancer patients: benefits and pitfalls(2011)348 cited
- → Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy(2008)340 cited
- → Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation(2013)336 cited
- → Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells(2019)333 cited
- → Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?(2012)309 cited
- → Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events(2020)258 cited
- → Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma(2019)232 cited
- → Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma(2013)222 cited
- → Primary central nervous system lymphoma(2023)215 cited